Vascular endothelial growth factor concentrations from platelets correlate with tumor angiogenesis and grading in a spontaneous canine non-Hodgkin lymphoma model

References

• Folkman J. Tumor angiogenesis and tissue factor. Nat Med 1996;2:209–215.
   PubMed Web of Science ®Google Scholar
• Patruno R, Arpaia N, Gadaleta CD, et al VEGF concentration from plasma activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model. J Cell Mol Med 2009;13:555–561.
   PubMed Web of Science ®Google Scholar
• Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 1991;324:1–8.
   PubMed Web of Science ®Google Scholar
• Ranieri G, Grammatica L, Patruno R, et al A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients. J Cell Mol Med 2007;11:362–368.
   PubMed Web of Science ®Google Scholar
• Kato Y, Asano K, Mogi T, et al Clinical significance of circulating vascular endothelial growth factor in dogs with mammary gland tumors. J Vet Med Sci 2007;69:77–80.
   PubMed Web of Science ®Google Scholar
• Wergin MC, Kaser-Hotz B. Plasma vascular endothelial growth factor (VEGF) measured in seventy dogs with spontaneously occurring tumours. In Vivo 2004;18:15–19.
   PubMed Web of Science ®Google Scholar
• Ranieri G, Coviello M, Chiriatti A, et al Vascular endothelial growth factor assessment in different blood fractions of gastrointestinal cancer patients and healthy controls. Oncol Rep 2004;11:435–439.
   PubMed Web of Science ®Google Scholar
• Ranieri G, Coviello M, Patruno R, et al Vascular endothelial growth factor concentrations in the plasma-activated platelets rich (P-APR) of healthy controls and colorectal cancer patients. Oncol Rep 2004;2:817–820.
   Google Scholar
• Clifford CA, Hughes D, Beal MW, et al Plasma vascular endothelial growth factor concentrations in healthy dogs and dogs with hemangiosarcoma. J Vet Intern Med 2001;15:131–135.
   PubMed Web of Science ®Google Scholar
• Hormbrey E, Gillespie P, Turner K, et al A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful? Clin Exp Metastasis 2002;19:651–663.
   PubMed Web of Science ®Google Scholar
• Werther K, Christensen IJ, Nielsen HJ. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Lab Invest 2002;62:343–350.
   PubMed Web of Science ®Google Scholar
• Salven P, Orpana A, Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 1999;5:487–491.
   PubMed Web of Science ®Google Scholar
• Verheul HM, Lolkema MP, Qian DZ, et al Platelets take up the monoclonal antibody bevacizumab. Clin Cancer Res 2007;13:5341–5347.
   PubMed Web of Science ®Google Scholar
• Verheul HMW, Hoekman K, de Bakker SL, et al Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 1997;3:2187–2190.
   PubMed Web of Science ®Google Scholar
• Gentilini F, Calzolari C, Turba ME, et al Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected dogs. Leuk Res 2005;29:1263–1269.
   PubMed Web of Science ®Google Scholar
• Ranieri G, Patruno R, Lionetti A, et al Endothelial area and microvascular density in a canine non-Hodgkin's lymphoma: an interspecies model of tumor angiogenesis. Leuk Lymphoma 2005;46:1639–1643.
   PubMed Web of Science ®Google Scholar
• Hazar B, Paydas Z, Zorludemir S, Sahin S, Tuncer I. Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma. Leuk Lymphoma 2003;44:2089–2093.
   PubMed Web of Science ®Google Scholar
• Vacca A, Ribatti D, Ruco L, et al Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Br J Cancer 1999;79:965–970.
   PubMed Web of Science ®Google Scholar
• Patruno R, Zizzo N, Zito AF, et al Microvascular density and endothelial area correlate with Ki-67 proliferative rate in the canine non-Hodgkin's lymphoma spontaneous model. Leuk Lymphoma 2006;47:1138–1143.
   PubMed Web of Science ®Google Scholar
• Vacca A, Ribatti D, Roncali L, Dammacco F. Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leuk Lymphoma 1995;20:27–38.
   PubMed Web of Science ®Google Scholar
• Ribatti D, Vacca A, Nico B, Fanelli M, Roncali L, Dammacco F. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur J Haematol 1996;56:45–53.
   PubMed Web of Science ®Google Scholar
• Troy GC, Huckle WR, Rossmeisl JH, et al Endostatin and vascular endothelial growth factor concentrations in healthy dogs, dogs with selected neoplasia, and dogs with nonneoplastic diseases. J Vet Intern Med 2006;20:144–150.
   PubMed Web of Science ®Google Scholar
• Fournel-Fleury C, Ponce F, Felman P, et al Canine T-cell lymphomas: a morphological, immunological, and clinical study of 46 new cases. Vet Pathol 2002;39:92–109.
   PubMed Web of Science ®Google Scholar
• Ferre L, Fondeila D, Rabanal R, Ramis A. Detection of T lymphocytes in canine tissue embedded in paraffin wax by means of antiboby to CD-3antigen. J Comp Path 1992;106:311–314.
   PubMed Web of Science ®Google Scholar
• Ranieri G, Passantino L, Patruno R, et al The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. Oncol Rep 2003;10:1189–1193.
   PubMed Web of Science ®Google Scholar
• Ranieri G, Gasparini G. Surrogate markers of angiogenesis and metastasis. In: Brooks S, editor. Metastasis research protocols. Oxford: Humana Press; 2001. pp 99–114.
   Google Scholar
• Ranieri G, Patruno R, Ruggieri E, Montemurro S, Valerio P, Ribatti D. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. Curr Med Chem 2006;13:1845–1857.
   PubMed Web of Science ®Google Scholar
• Rusk A, McKeegan E, Haviv F, Majest S, Henkin J, Khanna C. Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers. Clin Cancer Res 2006;12:7444–7455.
   PubMed Web of Science ®Google Scholar
• Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 2001;47:617–623.
   PubMed Web of Science ®Google Scholar
• Banks RE, Forbes MA, Kinsey SE, et al Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956–964.
   PubMed Web of Science ®Google Scholar
• Kut C, Mac Gabhann F, Popel AS. Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. Br J Cancer 2007;97:978–985.
   PubMed Web of Science ®Google Scholar
• Klement GL, Yip TT, Cassiola F, et al Platelets actively sequester angiogenesis regulators. Blood 2009;113:2835–2842.
   PubMed Web of Science ®Google Scholar
• Ria R, Cirulli T, Giannini T, Bambace S, et al Serum levels of angiogenic cytokines decrease after radiotherapy in non-Hodgkin lymphomas. Clin Exp Med 2008;8:141–145.
   PubMed Web of Science ®Google Scholar
• Etto L, Lacerda E, Baiocchi O, et al Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma. Leuk Lymphoma 2008;49:257–264.
   PubMed Web of Science ®Google Scholar
• Passam FH, Sfiridaki A, Pappa C, et al Angiogenesis-related growth factors and cytokines in the serum of patients with B non-Hodgkin lymphoma; relation to clinical features and response to treatment. Int J Lab Hematol 2008;30:17–25.
   PubMed Web of Science ®Google Scholar
• Gentilini F, Calzolari C, Turba ME, et al Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected dogs. Leuk Res 2005;29:1263–1269.
   PubMed Web of Science ®Google Scholar
• Salven P, Orpana A, Teerenhovi L, Joensuu H. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients. Blood 2000;96:3712–3718.
   PubMed Web of Science ®Google Scholar
• Longo R, Gasparini G. Anti-VEGF therapy: the search for clinical biomarkers. Expert Rev Mol Diagn 2008;8:301–314.
   PubMed Web of Science ®Google Scholar